Can this get any worse???, page-8

  1. 471 Posts.
    lightbulb Created with Sketch. 209
    Tr
    Yep that was what a lot of SRX shareholders were probably thinking when it it's SP dropped from $30 to $15. However it is now $13 an looks like a far more attractive option with an established product in the liver cancer salvage market with no debt and $100m in it's account that makes profit and currently buying back it's shares. Again DYOR but I know which horse I prefer to bet on!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.